CGEM R&D Expenses
Cullinan Therapeutics Inc · R&D Expenses
CGEM R&D Expenses
Latest reported$171.47Mperiod ending
CGEM R&D Expenses ($9.58M → $171.47M)
Annual R&D Expenses
High-resolution chart · PNG
CGEM r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 187,402,000 | |
| 142,903,000 | |
| 148,156,000 | |
| 91,948,000 | |
| 57,751,000 | |
| 43,211,000 | |
| 16,788,000 | |
| 9,584,000 |